Literature DB >> 23177279

The epidemiology of chronic hepatitis C and one-time hepatitis C virus testing of persons born during 1945 to 1965 in the United States.

John W Ward1.   

Abstract

Hepatitis C virus (HCV) is the most common blood-borne infection in the United States. HCV infection is a leading cause of chronic liver disease, end-stage liver disease, and liver transplantation. Newly available therapies can clear HCV in most infected persons who receive treatment. However, many persons living with HCV infection are unaware of their infection status, including those born during 1945-1965 (a population at increased risk for chronic hepatitis C in the United States). This review highlights the epidemiology of hepatitis C and the importance of HCV testing and linkage to care in an era of more effective antiviral therapies. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23177279     DOI: 10.1016/j.cld.2012.09.011

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  21 in total

1.  Association of Hepatitis C Virus Infection with Proteinuria and Glomerular Filtration Rate.

Authors:  Nargiza Kurbanova; Rehan Qayyum
Journal:  Clin Transl Sci       Date:  2015-08-14       Impact factor: 4.689

2.  High Hepatitis C Infection Rate Among Baby Boomers in an Urban Primary Care Clinic: Results from the HepTLC Initiative.

Authors:  Alexander G Geboy; Sandeep Mahajan; Allison P Daly; Candice F Sewell; Ike C Fleming; Hyun A Cha; Idene E Perez; Carmella A Cole; Adebisi A Ayodele; Dawn A Fishbein
Journal:  Public Health Rep       Date:  2016 May-Jun       Impact factor: 2.792

3.  Lack of health insurance limits the benefits of hepatitis C virus screening: insights from the National Health and Nutrition Examination Hepatitis C follow-up study.

Authors:  Ivo Ditah; Badr Al Bawardy; Humberto C Gonzalez; Behnam Saberi; Callistus Ditah; Patrick S Kamath; Michael Charlton
Journal:  Am J Gastroenterol       Date:  2015-03-10       Impact factor: 10.864

Review 4.  Hepatitis C virus: A time for decisions. Who should be treated and when?

Authors:  Bashar M Attar; David H Van Thiel
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

5.  Hepatitis C vaccine clinical trials among people who use drugs: potential for participation and involvement in recruitment.

Authors:  April M Young; Dustin B Stephens; Hanan A Khaleel; Jennifer R Havens
Journal:  Contemp Clin Trials       Date:  2014-12-30       Impact factor: 2.226

6.  Using qualitative data, people's perceptions, and the science of decision making to inform policy and improve hepatitis C care for people who use drugs.

Authors:  David C Perlman; Ashly E Jordan
Journal:  Int J Drug Policy       Date:  2014-10-31

7.  Effect of zinc supplementation on viral response in patients with chronic hepatitis C and Beta thalassemia major, a pilot study.

Authors:  Mohammad Abbasinazari; Seyed Moayed Alavian; Bita Behnava; Mansour Asgharinia; Shima Salimi; Maryam Keshvari; Leala Mehrnoush; Pegah Karim
Journal:  J Clin Diagn Res       Date:  2014-12-05

8.  Screening, detecting and enhancing the yield of previously undiagnosed hepatitis B and C in patients with acute medical admissions to hospital: a pilot project undertaken at the Vancouver General Hospital.

Authors:  Jordanna Kapeluto; Matthew Kadatz; Andrew Wormsbecker; Kiran Sidhu; Eric M Yoshida
Journal:  Can J Gastroenterol Hepatol       Date:  2014-06

9.  Comparison of Elecsys Anti-HCV II Assay With Other HCV Screening Assays.

Authors:  Dongdong Li; Siyuan Zhu; Tingting Wang; Jingna An; Lanlan Wang; Chuanmin Tao
Journal:  J Clin Lab Anal       Date:  2015-12-14       Impact factor: 2.352

10.  Economic Comparison of Serologic and Molecular Screening Strategies for Hepatitis C Virus.

Authors:  Sammy Saab; Timothy Ahn; Terina McDaniel; Beshoy Yanny; Myron J Tong
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.